| Conjugate | Catalog # | Availability | Size | Price |
|---|---|---|---|---|
| Alexa Fluor 488 | DDX1306A488 | |||
| Alexa Fluor 546 | DDX1306A546 | |||
| Alexa Fluor 647 | DDX1306A647 | |||
| Biotin | DDX1306B | |||
| Conjugate | Catalog # | Availability | Size | Price |
|---|---|---|---|---|
| Alexa Fluor 488 | DDX1304A488 | |||
| Alexa Fluor 546 | DDX1304A546 | |||
| Alexa Fluor 647 | DDX1304A647 | |||
| Biotin | DDX1304B | |||
| Conjugate | Catalog # | Availability | Size | Price |
|---|---|---|---|---|
| Alexa Fluor 488 | DDX1305A488 | |||
| Alexa Fluor 546 | DDX1305A546 | |||
| Alexa Fluor 647 | DDX1305A647 | |||
| Biotin | DDX1305B | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP1-76371-0.025mg | |||
| Conjugate | Catalog # | Availability | Size | Price |
|---|---|---|---|---|
| Biotin | NB100-65513 | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP2-41090-0.025mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NB120-14029-0.025mg | |||
![Western Blot: HIV-1 gp41 Antibody (425D11.01/ clone 3) [DDX1306] - Analysis of a purified multi-epitopic HIV antigen. The expected length of the HIV protein is 20 kDa. The second signal might represent a by-product.](http://images.novusbio.com/fullsize/HIV-1-gp41-Antibody-425D11-01-clone-3-Western-Blot-DDX1306-img0004.jpg "Western Blot: HIV-1 gp41 Antibody (425D11.01/ clone 3) [DDX1306] - Analysis of a purified multi-epitopic HIV antigen. The expected length of the HIV protein is 20 kDa. The second signal might represent a by-product.")
![Flow Cytometry: HIV-1 gp41 Antibody (425D11.01/ clone 3) [DDX1306] - FACS staining of HEK293-gp41TM cell line](http://images.novusbio.com/fullsize/HIV-1-gp41-Antibody-425D11-01-clone-3-Flow-Cytometry-DDX1306-img0001.jpg)
![Inhibition Activity: HIV-1 gp41 Antibody (425D11.01/ clone 3) [DDX1306] - Inhibition of HR1/HR2 fusion complex formation](http://images.novusbio.com/fullsize/HIV-1-gp41-Antibody-425D11-01-clone-3-Inhibition-Activity-DDX1306-img0002.jpg)
![Neutralization: HIV-1 gp41 Antibody (425D11.01/ clone 3) [DDX1306] - Neutralizing activities on laboratory strains and primary HIV-1 strains](http://images.novusbio.com/fullsize/HIV-1-gp41-Antibody-425D11-01-clone-3-Neutralization-DDX1306-img0003.jpg)
![Flow Cytometry: HIV-1 gp41 Antibody (402D9.14/clone 1) [DDX1304] - Analysis using the Alexa Fluor (R) 488 conjugate of DDX1304. A) Staining of HEK293-gp41TM cell line. B) Neutralizing activity.](http://images.novusbio.com/fullsize/HIV-1-gp41-Antibody-402D9-14-clone-1-Flow-Cytometry-DDX1304-img0006.jpg "Flow Cytometry: HIV-1 gp41 Antibody (402D9.14/clone 1) [DDX1304] - Analysis using the Alexa Fluor (R) 488 conjugate of DDX1304. A) Staining of HEK293-gp41TM cell line. B) Neutralizing activity.")
![Blocking/Neutralizing: HIV-1 gp41 Antibody (402D9.14/clone 1) [DDX1304] - Analysis using the Alexa Fluor (R) 488 conjugate of DDX1304. Inhibition of syncitia formation.](http://images.novusbio.com/fullsize/HIV-1-gp41-Antibody-402D9-14-clone-1-Blocking-Neutralizing-DDX1304-img0004.jpg)
![Blocking/Neutralizing: HIV-1 gp41 Antibody (402D9.14/clone 1) [DDX1304] - Analysis using the Alexa Fluor (R) 488 conjugate of DDX1304. Inhibition of HR1/HR2 fusion complex formation.](http://images.novusbio.com/fullsize/HIV-1-gp41-Antibody-402D9-14-clone-1-Blocking-Neutralizing-DDX1304-img0005.jpg)
![Flow Cytometry: HIV-1 gp41 Antibody (417D3.08/ clone 2) [DDX1305] - FACS staining of HEK293-gp41TM cell line](http://images.novusbio.com/fullsize/HIV-1-gp41-Antibody-417D3-08-clone-2-Flow-Cytometry-DDX1305-img0001.jpg "Flow Cytometry: HIV-1 gp41 Antibody (417D3.08/ clone 2) [DDX1305] - FACS staining of HEK293-gp41TM cell line")
![Inhibition Activity: HIV-1 gp41 Antibody (417D3.08/ clone 2) [DDX1305] - Inhibition of HR1/HR2 fusion complex formation](http://images.novusbio.com/fullsize/HIV-1-gp41-Antibody-417D3-08-clone-2-Inhibition-Activity-DDX1305-img0002.jpg)
![Neutralization: HIV-1 gp41 Antibody (417D3.08/ clone 2) [DDX1305] - Neutralizing activities on laboratory strains and primaryHIV-1 strains](http://images.novusbio.com/fullsize/HIV-1-gp41-Antibody-417D3-08-clone-2-Neutralization-DDX1305-img0003.jpg)
![Western Blot: HIV-1 gp120 Antibody [NBP1-76371] - Analysis of 5 ng of gp120 with gp120 antibody at 1 ug/mL.](http://images.novusbio.com/fullsize/HIV-1-gp120-Antibody-Western-Blot-NBP1-76371-img0003.jpg "Western Blot: HIV-1 gp120 Antibody [NBP1-76371] - Analysis of 5 ng of gp120 with gp120 antibody at 1 ug/mL.")
![Western Blot: HIV-1 gp120 Antibody [NBP2-41090] - Western blot analysis of (A) 25 and (B) 100 ng of gp120 with gp120 antibody at 1 ug/mL.](http://images.novusbio.com/fullsize/HIV-1-gp120-Antibody-Western-Blot-NBP2-41090-img0001.jpg "Western Blot: HIV-1 gp120 Antibody [NBP2-41090] - Western blot analysis of (A) 25 and (B) 100 ng of gp120 with gp120 antibody at 1 ug/mL.")
![Western Blot: HIV-1 gp120 Antibody [NBP3-06630] - NBP3-06630 at 1:1000 dilution. Sample: HIV-1 gp120 Protein (group M, subtype CRF07_BC) Recombinant Protein. Lane A: 50ng Lane B: 10ng Secondary Goat Anti-Rabbit IgG H&L (Dylight 800) at 1/10000 dilution. Developed using the Odyssey technique. Performed under reducing conditions.](http://images.novusbio.com/fullsize/nbp3-06630_rabbit-polyclonal-hiv-1-gp120-antibody-136202422345013.png "Western Blot: HIV-1 gp120 Antibody [NBP3-06630] - NBP3-06630 at 1:1000 dilution. Sample: HIV-1 gp120 Protein (group M, subtype CRF07_BC) Recombinant Protein. Lane A: 50ng Lane B: 10ng Secondary Goat Anti-Rabbit IgG H&L (Dylight 800) at 1/10000 dilution. Developed using the Odyssey technique. Performed under reducing conditions.")
![Western Blot: HIV-1 gp120 Antibody [NBP3-06424] - Anti-S3-HIV1Pgp120-His rabbit polyclonal antibody at 1:1000 dilution. Sample:S3-HIV1Pgp120-His Recombinant Protein. Lane A: 30ng. Secondary: HRP Conjugated Goat anti-rabbit IgG (H+L) at 1/1000 dilution. Performed under reducing conditions.](http://images.novusbio.com/fullsize/HIV-1-gp120-Antibody-Western-Blot-NBP3-06424-img0001.jpg "Western Blot: HIV-1 gp120 Antibody [NBP3-06424] - Anti-S3-HIV1Pgp120-His rabbit polyclonal antibody at 1:1000 dilution. Sample:S3-HIV1Pgp120-His Recombinant Protein. Lane A: 30ng. Secondary: HRP Conjugated Goat anti-rabbit IgG (H+L) at 1/1000 dilution. Performed under reducing conditions.")
![Western Blot: HIV-1 gp120 Antibody [NBP2-81822] - Western blot analysis 1 ng of recombinant HIV-1 gp120 with HIV-1 gp120 antibody at 1 ug/mL.](http://images.novusbio.com/fullsize/HIV-1-gp120-Antibody-Western-Blot-NBP2-81822-img0001.jpg "Western Blot: HIV-1 gp120 Antibody [NBP2-81822] - Western blot analysis 1 ng of recombinant HIV-1 gp120 with HIV-1 gp120 antibody at 1 ug/mL.")
![Dot Blot: HIV-1 Protease Antibody (1696) - BSA Free [NB500-337] - Fig. 1. Dot Blot analysis of recombinant HIV-1 Protease. The total amount of recombinant HIV-protease spotted on the nitrocellulose membrane are indicated in left column. Lane 1: anti-HIV-1 Protease (1696); 0.2 ug/ml Lane 2: anti-HIV-1 Protease (1696); 1.0 ug/ml Lane 3: anti-HIV-1 Protease (1696); 2.0 ug/ml](http://images.novusbio.com/fullsize/HIV-1-Protease-Antibody-1696-BSA-Free-Dot-Blot-NB500-337-img0002.jpg "Dot Blot: HIV-1 Protease Antibody (1696) - BSA Free [NB500-337] - Fig. 1. Dot Blot analysis of recombinant HIV-1 Protease. The total amount of recombinant HIV-protease spotted on the nitrocellulose membrane are indicated in left column. Lane 1: anti-HIV-1 Protease (1696); 0.2 ug/ml Lane 2: anti-HIV-1 Protease (1696); 1.0 ug/ml Lane 3: anti-HIV-1 Protease (1696); 2.0 ug/ml")
![ELISA: HIV-1 gp120 ELISA Kit (Colorimetric) [NBP2-80343] - Example standard curve for HIV-1 gp120 ELISA Kit (Colorimetric). These standard curves are provided for demonstration only. A standard curve should be generated for each set of samples assayed.](http://images.novusbio.com/fullsize/HIV-1-gp120-ELISA-Kit-Colorimetric-ELISA-NBP2-80343-img0001.jpg "ELISA: HIV-1 gp120 ELISA Kit (Colorimetric) [NBP2-80343] - Example standard curve for HIV-1 gp120 ELISA Kit (Colorimetric). These standard curves are provided for demonstration only. A standard curve should be generated for each set of samples assayed.")